15 hours Ago
Dr Agarwal’s Healthcare IPO Day 2 Live Updates: The initial public offering of Dr Agarwal's Healthcare Ltd, an eye care service provider supported by Temasek Holdings and TPG, recorded a 7 percent subscription rate on the first day of bidding on Wednesday. The retail investor segment experienced an 11% subscription, while the non-institutional investor quota saw a 6% subscription. The portion allocated for qualified institutional buyers (QIBs) is still available for subscription.
The employee allocation was subscribed at a rate of 9%, and the segment set aside for shareholders was booked at 14%. On Tuesday, Dr Agarwal Healthcare IPO announced it garnered over 875.5 crore from anchor investors.
The 3,027.26-crore Dr Agarwal IPO, with a price band of 382 to 402 per share, will conclude on January 31. Dr Agarwal Healthcare IPO consists of a new issue of up to 300 crore along with an Offer For Sale (OFS) of up to 6.
78 crore equity shares valued at 2,727.26 crore if priced at the highest point of the price range. Shareholders participating in the OFS include Arvon Investments Pte Ltd, Claymore Investments (Mauritius) Pte Ltd, and Hyperion Investments Pte Ltd.
The funds raised from the new issue, approximately 195 crore, will be allocated for debt repayment. Additionally, a portion of the funds will be directed towards general corporate needs and unspecified acquisitions. Dr Agarwal's Health Care offers a wide array of services, including cataract, refractive, and other surgeries, consultations, diagnosis, non-surgical treatments, and the sale of optical products, contact lenses, accessories, and eye care-related pharmaceutical items.
As of September 2024, the network included 193 facilities, primarily located in South India, especially in Chennai, Hyderabad, and Bengaluru, with a significant presence also in Western India. Dr Agarwal’s Healthcare IPO Day 2 Live Updates: Here's what GMP signal ahead of second bidding day Dr Agarwal's IPO GMP today is +5. This indicates Dr Agarwal's Healthcare share price was trading at a premium of 5 in the grey market, according to investorgain.
com. Considering the upper end of the IPO price band and the current premium in the grey market, the estimated listing price of Dr Agarwal's Healthcare share price is indicated at 407 apiece, which is 1.24% higher than the IPO price of 402.
Today's IPO GMP is pointing lower and is predicted to decline further based on grey market activity over the last 7 sessions. According to experts on investorgain.com, the lowest GMP is 5, and the highest is 54.
'Grey market premium' indicates investors' readiness to pay more than the issue price..
